Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design

Shesh N. Rai, Melissa M. Hudson, Elizabeth McCammon, Laura Carbone, Frances Tylavsky, Karen Smith, Harriet Surprise, John Shelso, Chin Hon Pui, Sue Kaste

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The BONEII study is a large two-phase study. The baseline study (Study 1) aims to estimate the prevalence of diminished bone mineral density (BMD) in patients treated for childhood acute lymphoblastic leukemia (ALL) and identify risk factors for BMD deficits. The interventional phase (Study 2) of BONEII has a placebo-controlled double-blind randomized longitudinal design to evaluate the effects of nutritional counseling and calcium and vitamin D supplementation on changes in BMD and serum and urine markers of bone metabolism. The extensive information being collected through this large study will serve as a repository of relational data about BMD and bone turnover and will support further investigations to assess the association of calcium metabolism, bone turnover, nutritional intake, lifestyle factors (such as exercise and the use of alcohol and tobacco), and the specific agents used in ALL therapy in this rapidly increasing population of childhood cancer survivors.

Original languageEnglish (US)
Pages (from-to)711-719
Number of pages9
JournalContemporary Clinical Trials
Volume29
Issue number5
DOIs
StatePublished - Sep 1 2008

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Density
Longitudinal Studies
Survivors
Placebos
Bone Remodeling
Calcium
Bone and Bones
Tobacco Use
Vitamin D
Life Style
Counseling
Biomarkers
Alcohols
Urine
Exercise
Population
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia : BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. / Rai, Shesh N.; Hudson, Melissa M.; McCammon, Elizabeth; Carbone, Laura; Tylavsky, Frances; Smith, Karen; Surprise, Harriet; Shelso, John; Pui, Chin Hon; Kaste, Sue.

In: Contemporary Clinical Trials, Vol. 29, No. 5, 01.09.2008, p. 711-719.

Research output: Contribution to journalArticle

Rai, Shesh N. ; Hudson, Melissa M. ; McCammon, Elizabeth ; Carbone, Laura ; Tylavsky, Frances ; Smith, Karen ; Surprise, Harriet ; Shelso, John ; Pui, Chin Hon ; Kaste, Sue. / Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia : BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. In: Contemporary Clinical Trials. 2008 ; Vol. 29, No. 5. pp. 711-719.
@article{6e1efeeffa404ee28bb216a2c50ef6ea,
title = "Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design",
abstract = "The BONEII study is a large two-phase study. The baseline study (Study 1) aims to estimate the prevalence of diminished bone mineral density (BMD) in patients treated for childhood acute lymphoblastic leukemia (ALL) and identify risk factors for BMD deficits. The interventional phase (Study 2) of BONEII has a placebo-controlled double-blind randomized longitudinal design to evaluate the effects of nutritional counseling and calcium and vitamin D supplementation on changes in BMD and serum and urine markers of bone metabolism. The extensive information being collected through this large study will serve as a repository of relational data about BMD and bone turnover and will support further investigations to assess the association of calcium metabolism, bone turnover, nutritional intake, lifestyle factors (such as exercise and the use of alcohol and tobacco), and the specific agents used in ALL therapy in this rapidly increasing population of childhood cancer survivors.",
author = "Rai, {Shesh N.} and Hudson, {Melissa M.} and Elizabeth McCammon and Laura Carbone and Frances Tylavsky and Karen Smith and Harriet Surprise and John Shelso and Pui, {Chin Hon} and Sue Kaste",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.cct.2008.05.002",
language = "English (US)",
volume = "29",
pages = "711--719",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia

T2 - BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design

AU - Rai, Shesh N.

AU - Hudson, Melissa M.

AU - McCammon, Elizabeth

AU - Carbone, Laura

AU - Tylavsky, Frances

AU - Smith, Karen

AU - Surprise, Harriet

AU - Shelso, John

AU - Pui, Chin Hon

AU - Kaste, Sue

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The BONEII study is a large two-phase study. The baseline study (Study 1) aims to estimate the prevalence of diminished bone mineral density (BMD) in patients treated for childhood acute lymphoblastic leukemia (ALL) and identify risk factors for BMD deficits. The interventional phase (Study 2) of BONEII has a placebo-controlled double-blind randomized longitudinal design to evaluate the effects of nutritional counseling and calcium and vitamin D supplementation on changes in BMD and serum and urine markers of bone metabolism. The extensive information being collected through this large study will serve as a repository of relational data about BMD and bone turnover and will support further investigations to assess the association of calcium metabolism, bone turnover, nutritional intake, lifestyle factors (such as exercise and the use of alcohol and tobacco), and the specific agents used in ALL therapy in this rapidly increasing population of childhood cancer survivors.

AB - The BONEII study is a large two-phase study. The baseline study (Study 1) aims to estimate the prevalence of diminished bone mineral density (BMD) in patients treated for childhood acute lymphoblastic leukemia (ALL) and identify risk factors for BMD deficits. The interventional phase (Study 2) of BONEII has a placebo-controlled double-blind randomized longitudinal design to evaluate the effects of nutritional counseling and calcium and vitamin D supplementation on changes in BMD and serum and urine markers of bone metabolism. The extensive information being collected through this large study will serve as a repository of relational data about BMD and bone turnover and will support further investigations to assess the association of calcium metabolism, bone turnover, nutritional intake, lifestyle factors (such as exercise and the use of alcohol and tobacco), and the specific agents used in ALL therapy in this rapidly increasing population of childhood cancer survivors.

UR - http://www.scopus.com/inward/record.url?scp=49949112378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49949112378&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2008.05.002

DO - 10.1016/j.cct.2008.05.002

M3 - Article

C2 - 18586578

AN - SCOPUS:49949112378

VL - 29

SP - 711

EP - 719

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 5

ER -